LS Investment Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,475
Closed -$12K 1545
2020
Q2
$12K Hold
3,475
﹤0.01% 1506
2020
Q1
$8K Hold
3,475
﹤0.01% 1586
2019
Q4
$13K Sell
3,475
-3,449
-50% -$27.9K ﹤0.01% 1624
2019
Q3
$57K Hold
6,924
﹤0.01% 1269
2019
Q2
$60K Hold
6,924
﹤0.01% 1253
2019
Q1
$74K Buy
6,924
+464
+7% +$4.97K ﹤0.01% 1179
2018
Q4
$57K Buy
6,460
+3,239
+101% +$41.3K ﹤0.01% 1235
2018
Q3
$54K Buy
3,221
+194
+6% +$4.2K ﹤0.01% 1307
2018
Q2
$63K Hold
3,027
﹤0.01% 1250
2018
Q1
$49K Buy
3,027
+150
+5% +$2.97K ﹤0.01% 1301
2017
Q4
$55K Sell
2,877
-340
-11% -$6.16K ﹤0.01% 1285
2017
Q3
$45K Buy
3,217
+397
+14% +$3.59K ﹤0.01% 1391
2017
Q2
$21K Hold
2,820
﹤0.01% 1575
2017
Q1
$18K Hold
2,820
﹤0.01% 1599
2016
Q4
$12K Hold
2,820
﹤0.01% 1660
2016
Q3
$13K Buy
2,820
+418
+17% +$2.48K ﹤0.01% 1628
2016
Q2
$16K Buy
2,402
+517
+27% +$3.65K ﹤0.01% 1559
2016
Q1
$12K Hold
1,885
﹤0.01% 1602
2015
Q4
$11K Hold
1,885
﹤0.01% 1637
2015
Q3
$11K Hold
1,885
﹤0.01% 1639
2015
Q2
$13K Buy
+1,885
New +$12K ﹤0.01% 1629

Other funds holding SPPI

LS Investment Advisors's SPPI Position: Q3 2020 in Review

LS Investment Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 3,475 shares — an estimated $12K sold.

LS Investment Advisors first reported a position in SPPI in Q2 2015 and held it in 21 quarters. The position peaked at $74K in Q1 2019. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

  • LS Investment Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 3,475 Spectrum Pharmaceuticals Inc shares in Q3 2020, an estimated $12K.
  • LS Investment Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2015 and held it in 21 quarters.
  • LS Investment Advisors's Spectrum Pharmaceuticals Inc position peaked at $74K in Q1 2019.
  • 159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.